Allied Blenders & Distillers Limited conducted its earnings conference call on July 24, 2026, to discuss the audited financial results for the first quarter of fiscal year 2027 (1QFY27). The session, held in Mumbai via audio mode, brought together funds, investors, and analysts to review the company’s standalone and consolidated performance for the quarter ended June 30, 2026. This disclosure fulfills the regulatory requirement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following the advance intimation issued on July 20, 2026.

The conference call commenced at 04:00 P.M. (IST) and concluded at 04:51 P.M. (IST). During the proceedings, management referenced only publicly available documents, ensuring that no Unpublished Price Sensitive Information (UPSI) was shared with participants. The audio recording of the call is now available for public access on the company’s investor relations website.

Regulatory Compliance and Disclosure

The intimation regarding the outcome of the earnings call was filed with both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE). The filing cites Regulation 30(6) read with Para A(15) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sumeet Maheshwari, Company Secretary & Compliance Officer of Allied Blenders & Distillers Limited, signed the communication, confirming adherence to listing obligations.

Key Details of the Earnings Call

The company emphasized that the discussion was strictly confined to the audited financial results already in the public domain. Investors seeking a detailed review of the management’s commentary can access the full audio recording through the provided weblink on the corporate website. This procedural update ensures transparency and equal access to information for all stakeholders in accordance with SEBI guidelines.

Allied Blenders & Distillers reported a 12% year-on-year increase in standalone net profit to ₹6,899 crore for the quarter ended June 30, 2026 (Q1FY27), driven by robust volume growth and margin expansion. However, consolidated net profit attributable to owners declined 18.7% to ₹454 crore from ₹558 crore in the corresponding period of the previous year, reflecting strategic investments in advertising and promotion for its premium portfolio.

The Board of Directors approved the unaudited financial results on July 23, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by Walker Chandio & Co LLP, the statutory auditor. The company published the results in The Free Press Journal and Navshakti newspapers on July 25, 2026, under Regulation 47 of the SEBI Listing Regulations.

Financial Performance

Standalone total income rose 1.2% to ₹18,003 crore from ₹17,794 crore in Q1FY26. Gross margins expanded by 277 basis points to 46.0%, while standalone EBITDA margins widened by 113 basis points to 14.3%. Standalone EBITDA reached ₹1,400 crore, up from ₹1,220 crore in the prior year period.

Consolidated figures showed a different dynamic, with EBITDA remaining broadly flat at ₹1,200 crore against ₹1,190 crore in Q1FY26. Consolidated margins contracted by 55 basis points to 12.2%. Management attributed this contraction to increased advertising and promotion spends for the ABD Maestro portfolio and supply chain headwinds. Excluding a ₹240 million supply chain impact, like-to-like consolidated EBITDA would have been ₹1,440 crore, representing a 21.4% increase with margins at 14.7%.

Operational Highlights

The Prestige & Above (P&A) segment delivered 9.0 million cases, marking a 6.2% year-on-year increase. Volume salience for this segment increased to 48.2% from 46.2%. ICONiQ White sales surged 33.8% to 3.1 million cases from 2.3 million cases in the previous year. The company expanded its international presence to 39 countries and launched Zoya Pink, a super-premium gin extension, in Maharashtra in April 2026.

Strategic Investments and Outlook

Management outlined a multi-year capital expenditure program aimed at enhancing EBITDA margins by approximately 300 basis points by FY28 and an incremental 100 basis points by FY29. Key investments include a ₹1,150 million PET packaging unit in Telangana, operational from Q3FY26, and a ₹750 million single malt distillery in Telangana expected in H1FY27. In Maharashtra, a ₹3,400 million acquisition in MAILLP is fully operational, with capacity expanding to 61.0 MLPA.

The company targets revenue growth in the mid-teens, underpinned by increasing P&A contribution reaching ~50% by volume by FY28. It aims to drive Return on Capital Employed (ROCE) from 18.5% in FY26 to 23–25% by FY28. Net debt reduced by ₹330 million to ₹9,470 crore in June 2026, maintaining Net Debt/EBITDA at 1.7x and Net Debt/Equity at 0.6x, well within the stated framework of <2.0x and <0.75x respectively.

Regulatory Disclosures

The company continues to contest a CSD debit memorandum demanding ₹33,987.20 lakh for differential trade rates on sales between March 1, 2012, and October 31, 2017. Arbitration hearings are scheduled for July 27 and 28, 2026. Regarding income tax litigation, the department revised the aggregate demand to ₹26,075.30 lakh and interest to ₹19,377.10 lakh via an order dated January 30, 2026. All penalty proceedings under Section 271(1)(c) were dropped.